During the last session, GlycoMimetics Inc (NASDAQ:GLYC)’s traded shares were 0.48 million, with the beta value of the company hitting 1.68. At the end of the trading day, the stock’s price was $0.22, reflecting an intraday loss of -10.68% or -$0.02. The 52-week high for the GLYC share is $3.16, that puts it down -1336.36 from that peak though still a striking 36.36% gain since the share price plummeted to a 52-week low of $0.14. The company’s market capitalization is $14.08M, and the average intraday trading volume over the past 10 days was 0.24 million shares, and the average trade volume was 1.43 million shares over the past three months.
GlycoMimetics Inc (GLYC) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 3.00. GLYC has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 0 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.05.
GlycoMimetics Inc (NASDAQ:GLYC) trade information
GlycoMimetics Inc (GLYC) registered a -10.68% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -10.68% in intraday trading to $0.22, hitting a weekly high. The stock’s 5-day price performance is -19.19%, and it has moved by -16.37% in 30 days. Based on these gigs, the overall price performance for the year is -92.34%. The short interest in GlycoMimetics Inc (NASDAQ:GLYC) is 2.58 million shares and it means that shorts have 0.71 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 15.18%. While earnings are projected to return -1.72% in 2025, the next five years will return 62.74% per annum.
GLYC Dividends
GlycoMimetics Inc is due to release its next quarterly earnings on 2025-Feb-12. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
GlycoMimetics Inc (NASDAQ:GLYC)’s Major holders
GlycoMimetics Inc insiders own 2.86% of total outstanding shares while institutional holders control 47.16%, with the float percentage being 48.56%. BVF INC/IL is the largest shareholder of the company, while 47.0 institutions own stock in it. As of 2024-06-30, the company held over 9.54 million shares (or 14.8071% of all shares), a total value of $2.69 million in shares.
The next largest institutional holding, with 8.59 million shares, is of ARTAL GROUP S.A.’s that is approximately 13.3252% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $2.42 million.
Also, the Mutual Funds coming in first place with the largest holdings of GlycoMimetics Inc (GLYC) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 1.93 shares. This amounts to just over 2.98 percent of the company’s overall shares, with a $0.42 million market value. The same data shows that the other fund manager holds slightly less at 730.6, or about 1.13% of the stock, which is worth about $0.16 million.
